These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2906457)

  • 1. Inhibition of food-stimulated acid secretion (intragastric titration) by roxatidine acetate. Dose-response study.
    Bonfils S; Chen WW; Vatier J
    Scand J Gastroenterol Suppl; 1988; 146():135-41. PubMed ID: 2906457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
    Chen WW; Kolsky H; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of roxatidine acetate (HOE-760) on 24-hour intragastric acidity in healthy volunteers: comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Müssig V; Neumann J; Scheurle E; Röhmel J; Walt RP
    Aliment Pharmacol Ther; 1988 Feb; 2(1):73-81. PubMed ID: 2908751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intragastric acidity in man: modern aspects, reproducibility of intragastric pH-monitoring, and pharmacodynamic results obtained with H2-receptor antagonists.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Muessig V; Neumann J; Scheurle E; Roehmel J; Walt RP
    Scand J Gastroenterol Suppl; 1988; 146():142-52. PubMed ID: 2906458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
    Hemery P; Congard P; Galmiche JP; Bonfils S
    Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trials.
    Merki HS; Bender W; Labs R
    J Clin Gastroenterol; 1989; 11 Suppl 1():S20-3; discussion S24. PubMed ID: 2572621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of roxatidine acetate on daytime and night-time peptone-stimulated gastric acid secretion.
    Hagenmüller F
    Drugs; 1988; 35 Suppl 3():65-8. PubMed ID: 2905251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
    Gladziwa U; Wagner S; Sieberth HG; Klotz U
    Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and biologic characteristics of roxatidine acetate.
    Bickel M; Herling AW; Schoelkens B; Scholtholt J
    Scand J Gastroenterol Suppl; 1988; 146():78-88. PubMed ID: 2906471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
    Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
    Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Cuban analog (SWR-104SA), a new histamine H2 receptor antagonist, on gastric acid secretion and experimental ulcer formation].
    Shinkawa R; Kiso T; Kataoka H; Isoi T; Kakita T; Shogaki T; Ohtsubo Y
    Yakugaku Zasshi; 1996 Oct; 116(10):783-91. PubMed ID: 8950870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacology of histamine H2-receptor antagonists.
    Sewing KF; Beil W; Hannemann H
    Drugs; 1988; 35 Suppl 3():25-9. PubMed ID: 2905246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
    Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
    Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of roxatidine acetate: a review.
    Dammann HG; de Looze SM; Bender W; Labs R
    Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bargiggia S; Bensi G; Canali A; Bianchi Porro G
    Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
    Chiverton SG; Burget DW; Hunt RH
    Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
    Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
    Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the novel histamine H2-antagonist 5,6-dimethyl-2-[4-[3-(1- piperidinomethyl)phenoxy]-(z)-2-butenylamino]-4(1H)-pyrimidine dihydrochloride on histamine-induced gastric acid secretion in Heidenhain pouch dogs.
    Uchida M; Ohba S; Ikarashi Y; Misaki N; Kawano O
    Arzneimittelforschung; 1993 Aug; 43(8):873-6. PubMed ID: 8105784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the animal pharmacology of roxatidine acetate.
    Scholtholt J; Bickel M; Herling AW
    Drugs; 1988; 35 Suppl 3():30-40. PubMed ID: 2905247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.